Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/j.1399-0012.2011.01543.x http://scihub22266oqcxt.onion/10.1111/j.1399-0012.2011.01543.x C5441562!5441562 !22032287     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\22032287 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Clin+Transplant 2012 ; 26 (3 ): 489-94 Nephropedia Template TP {{tp|p=22032287 |t=2012. Underutilization of A2 ABO incompatible kidney transplantation |pdf=|usr=}}{{22032287 }} gab.com Text Underutilization of A2 ABO incompatible kidney transplantation JO: Clin Transplant http://www.kidney.de/pget.php?&tw=1&pmid=22032287 #FOAvip BACKGROUND: ABO compatibility creates a disadvantage for O and B renal allograft candidates. A2 ABO incompatible transplant may decrease waiting times and generate equivalent graft survival to an ABO compatible transplant. METHODS: Death-censored graft survival was compared between A recipients and O, B, and AB recipients of an A2 allograft with multivariate Cox regression models utilizing data from the United Network of Organ Sharing (UNOS) between 1997 and 2007. RESULTS: Eighty-five percent of A2 kidneys were transplanted into ABO compatible recipients vs. 15% into ABO incompatible recipients. Rates of A2 incompatible kidney transplants did not increase over the study period (14.8% to 14.6%). Mean wait time for A2?O kidneys was 337 vs. 684 d for O?O and for A2?B kidneys, 542 vs. 734 d for B?B. Adjusted relative risk of graft loss at five-yr was similar between O, B, and AB recipients compared to A recipients of an A2 allograft, corresponding to a five-yr graft survival of 84%, 86.2%, 86.1%, and 86.1%, respectively. CONCLUSION: A2 incompatible kidney transplantation is underutilized. Graft outcomes are similar among A2 compatible and incompatible recipients. Shorter waiting time and improved access might be achieved if A2 kidneys are considered in all blood groups. Twit Text FOAVip Underutilization of A2 ABO incompatible kidney transplantation ????Clin Transplant http://www.kidney.de/pget.php?&tw=1&pmid=22032287 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=22032287 #FOAvip English Wikipedia <ref>{{Cite pmid|22032287 }}</ref> Underutilization of A2 ABO incompatible kidney transplantation #MMPMID22032287 Redfield RR ; Parsons RF ; Rodriguez E ; Mustafa M ; Cassuto J ; Vivek K ; Noorchashm H ; Naji A ; Levine MH ; Abt PL Clin Transplant 2012[May]; 26 (3 ): 489-94 PMID22032287 show ga BACKGROUND: ABO compatibility creates a disadvantage for O and B renal allograft candidates. A2 ABO incompatible transplant may decrease waiting times and generate equivalent graft survival to an ABO compatible transplant. METHODS: Death-censored graft survival was compared between A recipients and O, B, and AB recipients of an A2 allograft with multivariate Cox regression models utilizing data from the United Network of Organ Sharing (UNOS) between 1997 and 2007. RESULTS: Eighty-five percent of A2 kidneys were transplanted into ABO compatible recipients vs. 15% into ABO incompatible recipients. Rates of A2 incompatible kidney transplants did not increase over the study period (14.8% to 14.6%). Mean wait time for A2?O kidneys was 337 vs. 684 d for O?O and for A2?B kidneys, 542 vs. 734 d for B?B. Adjusted relative risk of graft loss at five-yr was similar between O, B, and AB recipients compared to A recipients of an A2 allograft, corresponding to a five-yr graft survival of 84%, 86.2%, 86.1%, and 86.1%, respectively. CONCLUSION: A2 incompatible kidney transplantation is underutilized. Graft outcomes are similar among A2 compatible and incompatible recipients. Shorter waiting time and improved access might be achieved if A2 kidneys are considered in all blood groups. |*Transplantation Immunology [MESH] |ABO Blood-Group System/*immunology [MESH] |Adult [MESH] |Blood Group Incompatibility/*immunology [MESH] |Female [MESH] |Follow-Up Studies [MESH] |Graft Survival/*immunology [MESH] |Humans [MESH] |Kidney Failure, Chronic [MESH] |Kidney Transplantation/*immunology/mortality/*statistics & numerical data [MESH] |Male [MESH] |Middle Aged [MESH] |Prognosis [MESH] |Retrospective Studies [MESH] |Survival Rate [MESH] |Tissue Donors [MESH]Underutilization of A2 ABO incompatible kidney transplantation (epmc).pdf DeepDyve Pubget Overpricing